Get complete visibility of QIAstat-Dx instrument status across your institute with push notifications in the QIAsphere app. The app works in harmony with your local network to help you maximize productivity – learn more in our connectivity guide.
During this unprecedented COVID-19 pandemic, data on novel SARS-CoV-2 variants with potentially increased transmissibility is rapidly developing. Confronting these new variants demands constant surveillance on diagnostic impact. Learn how our medical teams are working around the clock to empower your diagnostic labs.
Stay up to date on our continuous surveillance assessing the impact of mutations on assay sensitivity. (Updated January 2021)
To support the efforts for accessible testing to meet the demands of the COVID-19 outbreak, QIAGEN developed the QIAstat-Dx Respiratory SARS-CoV-2 Panel. This version of our multiplex syndromic cartridge detects and differentiates* 21 respiratory targets, including SARS-CoV-2.
The overlap of COVID-19 and influenza season is especially concerning as we may soon face two epidemics, or what some are calling a “twindemic”. Read about recent studies and what to expect this flu season in our resource hub.
How can labs get the results that doctors and patients need for effective treatment? Hear how Mako Medical, a full-service reference lab in North Carolina, delivers fast respiratory results for senior care populations.
Visit www.qiagen.com/coronavirus to learn more about how QIAGEN solutions can be used in the fight against COVID-19, or get in touch to let us know how we can support your lab.
Multiplex syndromic testing rapidly and simultaneously surveys a large number of pathogens, giving you the answers you need when you need them. Check out our infographic and learn more about syndromic testing for respiratory disease on the QIAstat-Dx!